214 related articles for article (PubMed ID: 28529116)
1. Italian consensus Guidelines for the management of hepatitis B virus infections in patients with rheumatoid arthritis.
Sebastiani M; Atzeni F; Milazzo L; Quartuccio L; Scirè C; Gaeta GB; Lapadula G; Armignacco O; Tavio M; Olivieri I; Meroni P; Bazzichi L; Grassi W; Mathieu A; Mastroianni C; Sagnelli E; Santantonio T; Uberti Foppa C; Puoti M; Sarmati L; Airò P; Epis OM; Scrivo R; Gargiulo M; Riva A; Manfredi A; Ciancio G; Zehender G; Taliani G; Meroni L; Sollima S; Sarzi-Puttini P; Galli M
Joint Bone Spine; 2017 Oct; 84(5):525-530. PubMed ID: 28529116
[TBL] [Abstract][Full Text] [Related]
2. Italian consensus recommendations for the management of hepatitis C infection in patients with rheumatoid arthritis.
Sebastiani M; Milazzo L; Atzeni F; Vacchi C; Manfredi A; Quartuccio L; Scirè C; Gaeta GB; Lapadula G; Armignacco O; Tavio M; D'Angelo S; Meroni P; Bazzichi L; Grassi W; Mathieu A; Mastroianni C; Sagnelli E; Santantonio T; Foppa CU; Puoti M; Sarmati L; Airò P; Epis OM; Scrivo R; Gargiulo M; Riva A; Ciancio G; Zehender G; Taliani G; Meroni L; Sollima S; Sarzi-Puttini P; Galli M
Mod Rheumatol; 2019 Nov; 29(6):895-902. PubMed ID: 30582388
[No Abstract] [Full Text] [Related]
3. Management of psoriasis patients with hepatitis B or hepatitis C virus infection.
Bonifati C; Lora V; Graceffa D; Nosotti L
World J Gastroenterol; 2016 Jul; 22(28):6444-55. PubMed ID: 27605880
[TBL] [Abstract][Full Text] [Related]
4. Discontinuation of antiviral prophylaxis correlates with high prevalence of hepatitis B virus (HBV) reactivation in rheumatoid arthritis patients with HBV carrier state: a real-world clinical practice.
Mo YQ; Liang AQ; Ma JD; Chen LF; Zheng DH; Schumacher HR; Dai L
BMC Musculoskelet Disord; 2014 Dec; 15():449. PubMed ID: 25532827
[TBL] [Abstract][Full Text] [Related]
5. Incidence and risk factors for reactivation from resolved hepatitis B virus in rheumatoid arthritis patients treated with biological disease-modifying antirheumatic drugs.
Watanabe T; Fukae J; Fukaya S; Sawamukai N; Isobe M; Matsuhashi M; Shimizu M; Akikawa K; Tanimura K; Atsumi T; Koike T
Int J Rheum Dis; 2019 Apr; 22(4):574-582. PubMed ID: 30338649
[TBL] [Abstract][Full Text] [Related]
6. The A, B, Cs of viral hepatitis in the biologic era.
Ferri C; Govoni M; Calabrese L
Curr Opin Rheumatol; 2010 Jul; 22(4):443-50. PubMed ID: 20386453
[TBL] [Abstract][Full Text] [Related]
7. Reactivation of hepatitis B virus in rheumatoid arthritis patients treated with biological disease-modifying antirheumatic drugs.
Nakamura J; Nagashima T; Nagatani K; Yoshio T; Iwamoto M; Minota S
Int J Rheum Dis; 2016 May; 19(5):470-5. PubMed ID: 24698305
[TBL] [Abstract][Full Text] [Related]
8. Kinetics of viral loads and risk of hepatitis B virus reactivation in hepatitis B core antibody-positive rheumatoid arthritis patients undergoing anti-tumour necrosis factor alpha therapy.
Lan JL; Chen YM; Hsieh TY; Chen YH; Hsieh CW; Chen DY; Yang SS
Ann Rheum Dis; 2011 Oct; 70(10):1719-25. PubMed ID: 21719446
[TBL] [Abstract][Full Text] [Related]
9. [Methotrexate, liver and rheumatoid arthritis in tropical areas].
Diouf ML; Diallo S; Mbengue M; Moreira-Diop T
Sante; 2001; 11(3):195-200. PubMed ID: 11641084
[TBL] [Abstract][Full Text] [Related]
10. NIH consensus development statement on management of hepatitis B.
Belongia EA; Costa J; Gareen IF; Grem JL; Inadomi JM; Kern ER; McHugh JA; Petersen GM; Rein MF; Sorrell MF; Strader DB; Trotter HT
NIH Consens State Sci Statements; 2008 Oct 22-24; 25(2):1-29. PubMed ID: 18949020
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B virus reactivation in patients with rheumatoid arthritis: A single-center study.
Matsuzaki T; Eguchi K; Nagao N; Tsuji S; Aramaki T; Terada K; Iwatsu S; Tokimura I; Kamo Y; Oda H; Kinoshita N; Miyaaki H; Taura N; Ichikawa T; Kawakami A; Nakao K; Ueki Y
Mod Rheumatol; 2018 Sep; 28(5):808-813. PubMed ID: 29256314
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B virus (HBV) reactivation in rheumatic patients with hepatitis core antigen (HBV occult carriers) undergoing anti-tumor necrosis factor therapy.
Lee YH; Bae SC; Song GG
Clin Exp Rheumatol; 2013; 31(1):118-21. PubMed ID: 23111095
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B virus screening and reactivation and management of patients with nasopharyngeal carcinoma: A large-scale, big-data intelligence platform-based analysis from an endemic area.
Lv JW; Chen YP; Huang XD; Zhou GQ; Chen L; Li WF; Tang LL; Mao YP; Guo Y; Xu RH; Ma J; Sun Y
Cancer; 2017 Sep; 123(18):3540-3549. PubMed ID: 28493307
[TBL] [Abstract][Full Text] [Related]
14. Reactivation of occult hepatitis B virus infection under treatment with abatacept: a case report.
Talotta R; Atzeni F; Sarzi Puttini P
BMC Pharmacol Toxicol; 2016 Apr; 17():17. PubMed ID: 27098382
[TBL] [Abstract][Full Text] [Related]
15. Short-course tocilizumab increases risk of hepatitis B virus reactivation in patients with rheumatoid arthritis: a prospective clinical observation.
Chen LF; Mo YQ; Jing J; Ma JD; Zheng DH; Dai L
Int J Rheum Dis; 2017 Jul; 20(7):859-869. PubMed ID: 28160426
[TBL] [Abstract][Full Text] [Related]
16. Safety of Abatacept in Rheumatoid Arthritis With Serologic Evidence of Past or Present Hepatitis B Virus Infection.
Padovan M; Filippini M; Tincani A; Lanciano E; Bruschi E; Epis O; Garau P; Mathieu A; Celletti E; Giani L; Tomietto P; Atzeni F; Sarzi Puttini P; Zuliani F; De Vita S; Trotta F; Grilli A; Puoti M; Govoni M
Arthritis Care Res (Hoboken); 2016 Jun; 68(6):738-43. PubMed ID: 26555747
[TBL] [Abstract][Full Text] [Related]
17. Management of acute hepatitis B and reactivation of hepatitis B.
Jindal A; Kumar M; Sarin SK
Liver Int; 2013 Feb; 33 Suppl 1():164-75. PubMed ID: 23286861
[TBL] [Abstract][Full Text] [Related]
18. Deleterious role of hepatitis B virus infection in therapeutic response among patients with rheumatoid arthritis in a clinical practice setting: a case-control study.
Chen YL; Lin JZ; Mo YQ; Ma JD; Li QH; Wang XY; Yang ZH; Yan T; Zheng DH; Dai L
Arthritis Res Ther; 2018 May; 20(1):81. PubMed ID: 29720221
[TBL] [Abstract][Full Text] [Related]
19. Management of patients with overt or resolved hepatitis B virus infection undergoing rituximab therapy.
Viganò M; Mangia G; Lampertico P
Expert Opin Biol Ther; 2014 Jul; 14(7):1019-31. PubMed ID: 24909454
[TBL] [Abstract][Full Text] [Related]
20. Prophylaxis of hepatitis B reactivation with immunosuppressive therapy in rheumatic diseases. Orientations for clinical practice.
Nunes J; Marinho RT; Fonseca JE; Pereira da Silva JA; Velosa J
Acta Reumatol Port; 2011; 36(2):110-8. PubMed ID: 21841730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
